| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc93eaa8f19bbed0b95d1a9497b06a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51078938081f2622afebce87ff7e8e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df538dfd9ff6e76ee2eb73996e0a483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d7019e2430a02ce116308adf5d9b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f1f7521fea3b95cabd13ab24f05e846 |
| publicationDate |
2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9867825-B2 |
| titleOfInvention |
Pharmaceutical combination comprising binimetinib |
| abstract |
A combination of a CDK4/6 inhibitor and a MEK inhibitor for the treatment of diseases such as cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973829-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019365741-A1 |
| priorityDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |